Does FOSTAMATINIB Cause Haemoglobin decreased? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Haemoglobin decreased have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 1.1% of all adverse event reports for FOSTAMATINIB.
72
Reports of Haemoglobin decreased with FOSTAMATINIB
1.1%
of all FOSTAMATINIB reports
1
Deaths
45
Hospitalizations
How Dangerous Is Haemoglobin decreased From FOSTAMATINIB?
Of the 72 reports, 1 (1.4%) resulted in death, 45 (62.5%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which FOSTAMATINIB Alternatives Have Lower Haemoglobin decreased Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM